These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 8835218)

  • 1. Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates.
    Wilmott RW; Amin RS; Perez CR; Wert SE; Keller G; Boivin GP; Hirsch R; De Inocencio J; Lu P; Reising SF; Yei S; Whitsett JA; Trapnell BC
    Hum Gene Ther; 1996 Feb; 7(3):301-18. PubMed ID: 8835218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA.
    Brody SL; Metzger M; Danel C; Rosenfeld MA; Crystal RG
    Hum Gene Ther; 1994 Jul; 5(7):821-36. PubMed ID: 7526901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung.
    Conrad CK; Allen SS; Afione SA; Reynolds TC; Beck SE; Fee-Maki M; Barrazza-Ortiz X; Adams R; Askin FB; Carter BJ; Guggino WB; Flotte TR
    Gene Ther; 1996 Aug; 3(8):658-68. PubMed ID: 8854091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
    Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A
    C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo adenovirus-mediated transfer of human CFTR cDNA to rhesus monkey airway epithelium: efficacy, toxicity and safety.
    Bout A; Imler JL; Schultz H; Perricaudet M; Zurcher C; Herbrink P; Valerio D; Pavirani A
    Gene Ther; 1994 Nov; 1(6):385-94. PubMed ID: 7584104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study.
    Simon RH; Engelhardt JF; Yang Y; Zepeda M; Weber-Pendleton S; Grossman M; Wilson JM
    Hum Gene Ther; 1993 Dec; 4(6):771-80. PubMed ID: 7514446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
    Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
    Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study.
    Goldman MJ; Litzky LA; Engelhardt JF; Wilson JM
    Hum Gene Ther; 1995 Jul; 6(7):839-51. PubMed ID: 7578403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosol-mediated delivery of recombinant adenovirus to the airways of nonhuman primates.
    Sené C; Bout A; Imler JL; Schultz H; Willemot JM; Hennebel V; Zurcher C; Valerio D; Lamy D; Pavirani A
    Hum Gene Ther; 1995 Dec; 6(12):1587-93. PubMed ID: 8664383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector.
    Dong JY; Wang D; Van Ginkel FW; Pascual DW; Frizzell RA
    Hum Gene Ther; 1996 Feb; 7(3):319-31. PubMed ID: 8835219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial.
    Bellon G; Michel-Calemard L; Thouvenot D; Jagneaux V; Poitevin F; Malcus C; Accart N; Layani MP; Aymard M; Bernon H; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Levrey H; Morel Y; Paulin C; Perraud F; Rodillon L; Sené C; So S; Touraine-Moulin F; Pavirani A
    Hum Gene Ther; 1997 Jan; 8(1):15-25. PubMed ID: 8989991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung.
    Yei S; Mittereder N; Wert S; Whitsett JA; Wilmott RW; Trapnell BC
    Hum Gene Ther; 1994 Jun; 5(6):731-44. PubMed ID: 7948135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis.
    Zuckerman JB; Robinson CB; McCoy KS; Shell R; Sferra TJ; Chirmule N; Magosin SA; Propert KJ; Brown-Parr EC; Hughes JV; Tazelaar J; Baker C; Goldman MJ; Wilson JM
    Hum Gene Ther; 1999 Dec; 10(18):2973-85. PubMed ID: 10609658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological response of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2.
    St George JA; Pennington SE; Kaplan JM; Peterson PA; Kleine LJ; Smith AE; Wadsworth SC
    Gene Ther; 1996 Feb; 3(2):103-16. PubMed ID: 8867858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of airway gene transfer with Ad2/CFTR2: aerosol administration in the nonhuman primate.
    McDonald RJ; Lukason MJ; Raabe OG; Canfield DR; Burr EA; Kaplan JM; Wadsworth SC; St George JA
    Hum Gene Ther; 1997 Mar; 8(4):411-22. PubMed ID: 9054516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA.
    Rosenfeld MA; Chu CS; Seth P; Danel C; Banks T; Yoneyama K; Yoshimura K; Crystal RG
    Hum Gene Ther; 1994 Mar; 5(3):331-42. PubMed ID: 7517189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety evaluation of hemagglutinating virus of Japan--artificial viral envelope liposomes in nonhuman primates.
    Tsuboniwa N; Morishita R; Hirano T; Fujimoto J; Furukawa S; Kikumori M; Okuyama A; Kaneda Y
    Hum Gene Ther; 2001 Mar; 12(5):469-87. PubMed ID: 11268281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine pattern in cystic fibrosis patients during antibiotic therapy and gene therapy using adenoviral vector.
    Reix P; Bellon G; Bienvenu J; Pavirani A; Levrey-Hadden H
    Eur Cytokine Netw; 2002; 13(3):324-30. PubMed ID: 12231476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.
    Knowles MR; Hohneker KW; Zhou Z; Olsen JC; Noah TL; Hu PC; Leigh MW; Engelhardt JF; Edwards LJ; Jones KR
    N Engl J Med; 1995 Sep; 333(13):823-31. PubMed ID: 7544439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector.
    Hay JG; McElvaney NG; Herena J; Crystal RG
    Hum Gene Ther; 1995 Nov; 6(11):1487-96. PubMed ID: 8573621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.